Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany.

doi:10.1111/j.1468-1331.2009.02702.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany.

European journal of neurology - 1 Nov 2009

Madzar D, Schulte C, Gasser T

Abstract excerpt

BACKGROUND AND PURPOSE: Mutations in the leucine-rich repeat kinase gene (LRRK2) have been shown to be the most common genetic cause of both familial and sporadic Parkinson's disease. Patients harboring LRRK2 mutations develop late onset PD that in most cases cannot be clinically distinguished fr...

Topics

Aged
Female
Gene Frequency
Genetic Predisposition to Disease
Genetic Testing
Germany
Haplotypes
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Male
Middle Aged
Mutation
Protein Serine-Threonine Kinases
Reverse Transcriptase Polymerase Chain Reaction
Supranuclear Palsy, Progressive

Source

Open in PubMed

Identifiers

PMID: 19538213
DOI: 10.1111/j.1468-1331.2009.02702.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-19538213-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics